| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645852 Butyric ester cyto-differtiating agents |
| 07/08/1997 | CA2081970C Hiv protease inhibitors useful for the treatment of aids |
| 07/08/1997 | CA2057913C N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 07/03/1997 | WO1997023637A1 Galactopyranosides and their use |
| 07/03/1997 | WO1997023614A1 Osteoprotegerin |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023500A1 Endothelial cell proliferation inhibitor and method of use |
| 07/03/1997 | WO1997023499A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | WO1997023494A1 Carbohydrate conjugated bio-active compounds |
| 07/03/1997 | WO1997023485A1 Heteroarylcarboxamide derivatives |
| 07/03/1997 | WO1997023480A1 Novel integrin receptor antagonists |
| 07/03/1997 | WO1997023478A1 Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/1997 | WO1997023476A1 HETEROCYCLYL-CONDENSED BENZOYLGUANIDINES, THEIR PRODUCTION AND USE AS INHIBITORS OF THE CELLULAR Na+/H+-ANTIPORTER |
| 07/03/1997 | WO1997023465A1 New barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 07/03/1997 | WO1997023464A1 Phenylimidazolidines and use thereof as an antiandrogenic agent |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023451A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | WO1997023447A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | WO1997023239A1 Dry compositions |
| 07/03/1997 | WO1997023236A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | WO1997023230A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | WO1997023223A1 Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 07/03/1997 | WO1997023218A1 A process for regulating vagal tone |
| 07/03/1997 | WO1997023214A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | DE19548709A1 Tyrosinderivate Tyrosine derivatives |
| 07/03/1997 | CA2241746A1 N-acylaminoalkylhydrazinecarboximidamides |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241255A1 Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase |
| 07/03/1997 | CA2241149A1 Tyrosin-derivate as alpha-v-integrin inhibitors |
| 07/03/1997 | CA2241143A1 Heterocyclyl-condensed benzoylguanidines, their production and use as inhibitors of the cellular na+/h+-antiporter |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2240941A1 Galactopyranosides and their use |
| 07/03/1997 | CA2240439A1 Novel integrin receptor antagonists |
| 07/03/1997 | CA2240038A1 4-substituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
| 07/03/1997 | CA2239909A1 Use of toxin peptides and/or affinity handles for the delivering compounds into cells |
| 07/03/1997 | CA2238873A1 Cell activation process and reagents therefor |
| 07/03/1997 | CA2238737A1 Prodrugs of thrombin inhibitors |
| 07/03/1997 | CA2213489A1 Carbohydrate conjugated bio-active compounds |
| 07/02/1997 | EP0781778A1 Novel paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy |
| 07/02/1997 | EP0781766A1 Heterocyclic derivative and medicine |
| 07/02/1997 | EP0781555A1 Benzothiophene formulations of a specific dosage |
| 07/02/1997 | EP0781550A1 Bioadhesive pharmaceutical composition for the controlled release of active agents |
| 07/02/1997 | EP0781326A1 The irs family of genes |
| 07/02/1997 | EP0781286A1 7,7-disubstituted cephem-4-ketones |
| 07/02/1997 | EP0781280A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 07/02/1997 | EP0781279A1 Quinoxalinedione nmda receptor antagonists |
| 07/02/1997 | EP0781139A1 Intracellular delivery of chemical agents to a specific cell type |
| 07/02/1997 | EP0781138A2 Lipid analogs for treating viral infections |
| 07/02/1997 | EP0730588B1 Isoxazoline compounds as antiinflammatory agents |
| 07/02/1997 | EP0703911B1 Secondary amines as antidiabetic and antiobesity agents |
| 07/01/1997 | US5644053 Beta-lactamase inhibitors or bactericide antibiotics |
| 07/01/1997 | US5643964 Natural amino acid derivatives as metalloproteinase inhibitors |
| 07/01/1997 | US5643946 Compounds useful for treating allergic and inflammatory diseases |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles |
| 07/01/1997 | US5643925 Benzene derivatives having NGF production-promoting activity |
| 07/01/1997 | US5643921 Cardiopulmonary bypass and organ transplant using a potassium channel activator |
| 07/01/1997 | US5643917 4-aminomethyl-1-azaadamantane derived benzamides |
| 07/01/1997 | US5643908 Collagenase inhibitor |
| 07/01/1997 | US5643896 2-Benzyl-3-arylbenzothiophenes |
| 07/01/1997 | US5643893 Antiinflammatory agents or antiarthritic agents |
| 07/01/1997 | US5643884 Antiinflammatory agents |
| 07/01/1997 | US5643879 Oligopeptide enzyme inhibitors as hypotensive agents |
| 07/01/1997 | US5643874 Pharmaceutical composition comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor |
| 07/01/1997 | US5643749 Soluble interferon α-receptor, its preparation and use |
| 07/01/1997 | US5643720 Method of inhibiting transcription utilizing nuclear receptors |
| 07/01/1997 | US5643623 Health food product and its uses |
| 07/01/1997 | US5643598 Method of skin care utilizing liposomes containing Scutellaria extracts |
| 06/26/1997 | WO1997022697A1 TGFβ SIGNAL TRANSDUCTION PROTEINS, GENES, AND USES RELATED THERETO |
| 06/26/1997 | WO1997022620A1 Oligopeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022609A1 4-substituted cephem derivatives as elastase inhibitors |
| 06/26/1997 | WO1997022604A1 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases |
| 06/26/1997 | WO1997022600A1 N-substituted dioxothiazolidylbenzamide derivatives and process for producing the same |
| 06/26/1997 | WO1997022597A1 Piperazine derivatives as tachykinin antagonists |
| 06/26/1997 | WO1997022596A1 Quinazoline derivatives |
| 06/26/1997 | WO1997022587A1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/26/1997 | WO1997022586A1 Tri-aryl ethane derivatives as pde iv inhibitors |
| 06/26/1997 | WO1997022359A1 Combination of g-csf with a chemotherapeutic agent for stem cell mobilisation |
| 06/26/1997 | WO1997022358A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | WO1997022348A1 Method and material for hair therapy |
| 06/26/1997 | WO1997022341A1 Endothelin receptor antagonists |
| 06/26/1997 | WO1997022250A1 Therapeutic molecules generated by trans-splicing |
| 06/26/1997 | DE19608753C1 Transduction system based on rep-negative adeno-associated virus vector |
| 06/26/1997 | DE19549232A1 Verwendung von G-CSF in Kombination mit einem Chemotherapeutikum zur Herstellung eines pharmazeutischen Präparates zur verstärkten Mobilisierung hämatopoetischer Stammzellen Use of G-CSF in combination with a chemotherapeutic agent for the preparation of a pharmaceutical composition for enhanced mobilization of hematopoietic stem cells |
| 06/26/1997 | DE19548708A1 Cyclische Sulfone Cyclic sulfones |
| 06/26/1997 | DE19548624A1 Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel New barbituric acid derivatives, processes for their preparation and medicaments containing these compounds |
| 06/26/1997 | DE19547324A1 cDNA encoding human mucin 8 |
| 06/26/1997 | CA2240640A1 Microemulsion preconcentrates comprising cyclosporins |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/26/1997 | CA2239126A1 Tgf.beta. signal transduction proteins, genes, and uses related thereto |
| 06/26/1997 | CA2238052A1 Method and material for hair therapy |
| 06/25/1997 | EP0780397A2 New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780388A1 5HT1Dalpha and 5HT2A ligands |